HomeNDC LookupIngredientsTriamcinolone Acetonide › 60505-6275-07
Triamcinolone acetonide 55 ug Spray, Metered — NDC 60505-6275-07 package photo

Triamcinolone acetonide 55 ug Spray, Metered

by Apotex Corp. · 1 BOTTLE, SPRAY in 1 CARTON (60505-6275-7) / 120 SPRAY, METERED in 1 BOTTLE, SPRAY
NDC 60505-6275-07
🏷️ FDA NDC (as labeled) 60505-6275-7 billing pads the package segment with a zero
OTC Generic On market Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
⚠️
Other active recalls for Triamcinolone Acetonide (different manufacturers) — 1 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Sep 28, 2023 — Presence of Particulate Matter: A product complaint of a piece of glass was identified in a vial. The piece of glass appears to be roughly 1 cm x 0.5 cm inside the vial. (Eugia US LLC) · FDA recall D-0041-2024
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

🆔 Identity & classification

FDA NDC (as labeled) 60505-6275-7
Product NDC 60505-6275
11-digit billing NDC 60505627507
NCPDP billing unit ML — per mL (volume)
RxCUI 1797913
UNII F446C597KA
Application # ANDA214615
SPL Set ID a0cde3d7-4934-ed19-78c0-01f21275cba0
Established class (EPC) Corticosteroid
Mechanism of action Corticosteroid Hormone Receptor Agonists
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2024-01-26
Route NASAL
Dosage form SPRAY, METERED
Substance TRIAMCINOLONE ACETONIDE
GPI-14 42200060103210
GCN Seq No 072054
GCN 36145
HICL code 002891
Ingredient (HICL) Triamcinolone Acetonide
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q7
Therapeutic class — intermediate (HIC2) Nasal Preparations
HIC3 code Q7P
Therapeutic class — specific (HIC3) Nasal Anti-Inflammatory Steroids
AHFS code 48:10.08.00
AHFS class Corticosteroids (Respiratory Tract)
FDB label name TRIAMCINOLONE 55 MCG NASAL SPR
FDB brand name Triamcinolone Acetonide
Legend status O — Over-the-counter (OTC) drug or device
Why two NDCs? The FDA registers this code as 60505-6275-7 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 60505-6275-07. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏷️ RxNorm drug class

This medicine belongs to the Corticosteroid class.

Pharmacologic class Corticosteroid
Drug family (ATC) Corticosteroids for local oral treatment, Corticosteroids, Corticosteroids, moderately potent (group II)
How it works Corticosteroid Hormone Receptor Agonists
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

🏭 Manufacturer & labeler

LabelerApotex Corp.
Application holderAPOTEX INC
FDA applicationANDA214615 (ANDA)
Labeler code60505
First marketedJan 2024
Product typeHuman Otc Drug
Portfolio306 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

Label name TRIAMCINOLONE 55 MCG NASAL SPR Ingredient Triamcinolone Acetonide
📖 What it is MedlinePlus · NLM

Triamcinolone nasal spray is used to relieve sneezing, runny, stuffy, or itchy nose and itchy, watery eyes caused by hay fever or other allergies. Triamcinolone nasal spray should not be used to treat symptoms (e.g., sneezing, stuffy, runny, or itchy nose) caused by the common cold. Triamcinolone is in a class of medications called corticosteroids. It works by blocking the release of certain natural substances that cause allergy symptoms.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • Yes, intra-articular triamcinolone is specifically approved to give short-term relief for knee arthritis, gout flares, bursitis, and similar joint conditions. The extended-release...
  • I'm getting a triamcinolone injection in my knee. Will it actually help, and how long does it last?
  • That's a really important thing to flag with your doctor before your injection or prescription. Triamcinolone can raise blood sugar — even in people whose diabetes is well-controll...
  • I have diabetes. Should I be worried about using triamcinolone?
📖 Read our full Triamcinolone guide →
8
Nutrient depletion considerations

Triamcinolone Acetonide may be associated with lower levels of 8 nutrients — worth a chat with your pharmacist, not a cause for alarm.

An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII F5UM2KM3W7
    Benzalkonium chloride is a chemical compound that works as a preservative and antimicrobial agent in medications. It prevents bacterial and fungal growth in liquid formulations to keep the product safe during storage and use.
  • UNII K679OBS311
    Carboxymethylcellulose sodium is a plant-derived thickening agent made from cellulose. In medicines, it acts as a binder to hold ingredients together, a disintegrant to help the tablet break apart, or a thickener in liquids.
  • UNII LX22YL083G
    A simple sugar derived from corn or other sources. It acts as a filler to give the medicine bulk and volume, and as a sweetener to improve taste in oral medications.
  • UNII 7FLD91C86K
    Edetate disodium is a chemical compound that binds and removes certain metal ions. In medicines, it acts as a preservative and stabilizer by preventing metals like calcium from interfering with the product's shelf life and consistency.
  • UNII QTT17582CB
    A strong acid used to adjust and maintain the proper pH level in liquid medicines, ensuring stability and preventing breakdown of active ingredients.
  • UNII OP1R32D61U
    Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
  • UNII 6OZP39ZG8H
    Polysorbate 80 is a synthetic emulsifier derived from sorbitol and oleic acid. It helps mix oil and water-based ingredients together in medications and improves how the product disperses in the body.
  • UNII 55X04QC32I
    A strong alkaline chemical used to adjust and maintain the pH balance of liquid medicines. It helps keep the medicine stable and ensures it stays effective during storage.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

9 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesbenzalkonium chloride solution (50% W/V) dextrose monohydrate, edetate disodium dihydrate, hydrochloric acid, microcrystalline cellulose, polysorbate 80 purified water & sodium hydroxide  

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMedingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly $0.742
Medicaid paysCMS SDUD · 12 mo $0.9827
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per mL) — tap or hover for the price & month
Dec 2025 Feb 2026 May 2026 Aug 2026 $0.772 $0.730
▲ Up 1% over the last 9 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Good Sense Nasal Allergy 55 ug 00113-0443-01 L. 1 bottle $0.742 Availability likely
Nasal Allergy 55 ug 00536-1457-69 Rugby 1 bottle $0.742 Availability likely
Triamcinolone Acetonide Nasal 55 ug 45802-0109-01 Padagis 1 bottle $0.742 Availability likely
Good Neighbor Pharmacy 24 Hour Nasal Allergy 55 ug 46122-0385-76 Amerisource 1 bottle $0.742 Availability likely
Triamcinolone acetonide 55 ugthis 60505-6275-07 Apotex 1 bottle $0.742 Availability likely
Triamcinolone acetonide 55 ug 70000-0702-01 CARDINAL 1 bottle $0.742 Availability likely
Triamcinolone Acetonide 55 ug 70000-0742-01 CARDINAL 1 bottle $0.742 Availability likely
foster and thrive 24 hour nasal allergy 55 ug 70677-1023-01 Strategic 1 bottle $0.742 Availability likely
Allergy Nasal 55 ug 00363-0811-01 Walgreen 1 bottle FDA listed
Up and Up Nasal Allergy 55 ug 11673-0717-01 Target 1 bottle FDA listed
Nasal Allergy 55 ug 11822-0443-01 Rite 1 bottle Discontinued
Signature Care Nasal Allergy 55 ug 21130-0443-01 Safeway 1 bottle FDA listed
Nasal Allergy 55 ug 21130-0613-02 Safeway 1 bottle FDA listed
Nasal Allergy Relief 55 ug 30142-0665-01 Kroger 1 bottle FDA listed
nasal allergy 55 ug 30142-0813-01 Kroger 1 bottle FDA listed
Topcare Nasal Allergy 55 ug 36800-0621-01 Topco 1 bottle FDA listed
Nasal Allergy 55 ug 37808-0443-01 H 1 bottle FDA listed
Equaline nasal allergy 55 ug 41163-0443-01 United 1 bottle FDA listed
Nasacort Allergy 24HR 55 ug 41167-5800-01 Chattem, 1 bottle FDA listed
24 Hour Nasal Allergy 55 ug 41250-0443-01 Meijer 1 bottle FDA listed
CareOne Allergy Relief 55 ug 41520-0443-01 American 1 bottle Discontinued
Equate Nasal Allergy 55 ug 49035-0443-01 Wal-Mart 1 bottle FDA listed
Nasacort 55 ug 50090-1444-00 A-S 1 bottle FDA listed
allergy relief 55 ug 51316-0711-01 CVS 1 bottle FDA listed
DG Health Nasal Allergy 55 ug 55910-0280-02 Dolgencorp, 1 bottle FDA listed
Nasal Allergy 55 ug 59779-0746-01 CVS 1 bottle FDA listed
Triamcinolone acetonide 55 ug 69168-0482-01 Allegiant 1 bottle FDA listed
Triamcinolone Acetonide Nasal 55 ug 72162-2289-02 Bryant 1 bottle FDA listed
Basic Care Nasal Allergy 55 ug 72288-0443-01 Amazon.com 1 bottle FDA listed
Nasal Allergy 55 ug 42507-0443-01 HyVee 1 bottle FDA listed
Triamcinolone Acetonide 55 ug 58602-0035-07 Aurohealth 1 bottle FDA listed
Childrens Triamcinolone Acetonide 55 ug 58602-0037-11 Aurohealth 1 bottle FDA listed
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2024
On the market since
Jan 2024
📍
2026
Currently FDA-listed
2 years listed
🔓
·
Generic on the market
this product is a generic
This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

🗺️ Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for 60505-6275-07, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q4 2025 · 4 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
7.6K
Units reimbursed last 4 qtrs
139K
Gross reimbursed last 4 qtrs
$136.6K
Avg / prescription
$18.08
Avg / unit
$0.9827
Latest quarter Q4 2025
801Rx
Medicaid pays / mL
$0.9827
gross reimbursed
vs
NADAC / mL
$0.7419
acquisition cost
=
Spread
+$0.2408
+32% vs cost
What Medicaid paid per mL (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care
46% FFS 54% MCO
Fee-for-service · 3,474 Rx Managed care · 4,082 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: 2,484 units · 31.8 per 100k residents WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: 303 units · 5.3 per 100k residents MN Wisconsin: no data reported WI Michigan: 811 units · 8.1 per 100k residents MI New York: 20,913 units · 107 per 100k residents NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: 473 units · 11.2 per 100k residents OR Nevada: 2,451 units · 76.7 per 100k residents NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: 237 units · 1.9 per 100k residents IL Indiana: 2,890 units · 42.1 per 100k residents IN Ohio: 13,419 units · 114 per 100k residents OH Pennsylvania: 1,572 units · 12.1 per 100k residents PA New Jersey: 4,191 units · 45.1 per 100k residents NJ Massachusetts: 19,063 units · 272 per 100k residents MA California: 27,936 units · 71.7 per 100k residents CA Utah: no data reported UT Colorado: 2,822 units · 48.0 per 100k residents CO Nebraska: 220 units · 11.1 per 100k residents NE Missouri: 423 units · 6.8 per 100k residents MO Kentucky: 4,614 units · 102 per 100k residents KY West Virginia: no data reported WV Virginia: 4,157 units · 47.7 per 100k residents VA Maryland: 10,884 units · 176 per 100k residents MD Connecticut: 2,518 units · 69.6 per 100k residents CT Rhode Island: 1,099 units · 100 per 100k residents RI Arizona: 2,383 units · 32.1 per 100k residents AZ New Mexico: 439 units · 20.8 per 100k residents NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: 3,448 units · 64.2 per 100k residents SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: 8,230 units · 74.6 per 100k residents GA D.C.: 321 units · 47.3 per 100k residents DC Hawaii: 693 units · 48.3 per 100k residents HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
1.9272
gray = no data reported
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Massachusetts 272 /100k
2 Maryland 176 /100k
3 Ohio 114 /100k
4 New York 107 /100k
5 Kentucky 102 /100k
6 Rhode Island 100 /100k
7 Nevada 76.7 /100k
8 Georgia 74.6 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

📊 Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Triamcinolone Acetonide — the program that covers self-administered drugs. 22 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Triamcinolone Acetonide. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$17.79M
Claims incl. refills
1.7M
Beneficiaries
1.4M
Spend / beneficiary
$13.01
Spend / claim
$10.45
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

🔬 Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Triamcinolone Acetonide — the ingredient across all brands.

Top reported reactions

Pruritus2,650
Rash2,534
Pain2,232
Fatigue2,133
Nausea2,043
Headache1,916
Condition Aggravated1,747

Reporter sex

31,697 reports
Male · 34%
Female · 66%
Unknown · 0%

Serious outcomes

Hospitalization6,577
Death3,076
Disabling2,415
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 4,201 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
60505-6275-07 You're viewing this 1 BOTTLE, SPRAY in 1 CARTON (60505-6275-7) / 120 SPRAY, METERED in 1 BOTTLE, SPRAY 2024-01-26 Active

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 19 words

Uses Temporarily relieves these symptoms of hey fever or other respiratory allergies: nasal congestion runny nose sneezing itchy nose

⏱️ Dosage and Administration ~1 min read

Directions Read insert (inside package) on how to: get a new bottle ready (primed) before first use prime bottle again if not used for more than 2 weeks use the spray clean the spray nozzle ADULTS AND CHILDREN 12 YEARS OF AGE AND OLDER adults and children 12 years of age and older once daily, spray 2 times into each nostril while sniffing gently once your allergy symptoms improve, reduce to 1 spray in each nostril CHILDREN 2 TO UNDER 12 YEARS OF AGE the growth rate of some children may be slower while using this product.

Talk to your child’s doctor if your child needs to use the spray longer than two months a year. children 6 to under 12 years of age an adult should supervise use once daily, spray 1 time into each nostril while sniffing gently if allergy symptoms do not improve, increase to 2 sprays in each nostril per day. Once allergy symptoms improve, reduce to 1 spray in each nostril per day. children 2 to under 6 years of age an adult should supervise use once daily, spray 1 time into each nostril while sniffing gently children under 2 years of age do not use do not use more than directed if you forget a dose, do not double the next dose do not spray into eyes or mouth if allergy symptoms do not improve after one week, stop using and talk to a doctor do not use for the common cold shake well before each use

⚠️ Warnings 217 words

Warnings For external use only Do not use In children under 2 years of age If you have ever had an allergic reaction to any of the ingredients Ask a doctor before use if you have had recent nose ulcers or nose surgery have had a nose injury that has not healed are using a steroid medicine for asthma, allergies or skin rash have an eye infection have or had glaucoma or cataracts When using this product the growth rate of some children may be slower some symptoms may get better on the first day of treatment. It may take up to one week of daily use to feel the most symptom relief. do not share this bottle with anyone else as this may spread germs remember to tell your doctor about all the medicines you take, including this one Stop use and ask a doctor if you have, or come in contact with someone who has, chickenpox, measles or tuberculosis you have or develop symptoms of an infection such as persist fever you have any change in vision you have severe or frequent nosebleeds If pregnant or breast-feeding , ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

🧪 Active Ingredient 10 words

Active ingredient (in each spray) Triamcinolone acetonide 55 mcg (glucocorticoid)

🧪 Inactive Ingredients 23 words

Inactive ingredients benzalkonium chloride solution (50% W/V) dextrose monohydrate, edetate disodium dihydrate, hydrochloric acid, microcrystalline cellulose, polysorbate 80 purified water & sodium hydroxide

🎯 Purpose 4 words

Purpose Allergy symptom reliever

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.